Cradle’s AI-powered protein programming platform levels up with $24M in new funding

Biotech and AI startup Cradle has raised $24 million in new investment and secured major customers such as Johnson & Johnson and Novozymes. Cradle takes a generative approach to protein design, using AI models to understand the molecular structure of proteins. By doing so, they can significantly reduce the time and number of experiments needed to create functional proteins. The company’s software has shown promising results, with 70% of protein variants produced by Cradle demonstrating increased stability compared to the industry average of under 5%. Cradle is also working on various projects internally, including decontaminating soil and developing growth factors for cultured meat products. The company plans to use the funding to expand its team and sales efforts.